Our Companies

The LSI family of companies provides expertise in analysis and strategic implementation of healthcare reform issues that impact health plans, providers, managed markets and industry.  15 years of deep expertise provide extensive experience in the healthcare space across a wide range of managed care, provider, pharmaceutical, device, and diagnostic businesses.

LSI provides reimbursement, payer relations, and health economics services through its companies consisting of extensive teams of highly experienced professionals from the medical technology, biotechnology, pharmaceutical and healthcare industries. 

LSI offers a full scope of reimbursement, payer relations, health economics and clinical trial design optimization services for product clearance (FDA and CE Mark) and coverage from government and private payers.  We have clients throughout the world including Norway, Sweden, Denmark, the UK, Belgium, France, Germany, Switzerland, Japan, Brazil and Canada. We help clients worldwide bring products to the U.S., European and Asian markets.

We understand the demands of global medical product launches and brings together seasoned local expertise and key relationships for each target market. LSI offers a range of services to support pharmaceutical, medical device, and diagnostic companies achieve and maintain adequate reimbursement overseas. Our services range from basic market assessments to marketing dossiers, to hands-on execution of dossier submissions and in-country advocacy efforts.  We cover all major global markets. Our in-country experts are specialized in market access, with both the technical knowledge and relationships to achieve optimal results.